FOXP3 and breast carcinoma: A few studies have indicated that CCL22 secreted by solid tumor cells is responsible for accumulation of Foxp3 +Tregs in ovarian [6], prostate [11], gastric [12], esophageal [13], and breast carcinomas [7,9].